Evotec AG: Results of Pre-Clinical Studies Lead to Reduction in Revenues, Nevertheless Profitable and More Than EURO 90 M Cash for 2013 Confirmed
13 déc. 2013 04h31 HE
|
Evotec AG
HAMBURG, Germany, Dec. 13, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) today announced that it is adjusting its guidance regarding...
Evotec Receives Pre-Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim
10 déc. 2013 01h46 HE
|
Evotec AG
HAMBURG, Germany, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone...
Evotec AG Reports First Nine Months 2013 Results
12 nov. 2013 01h56 HE
|
Evotec AG
DRIVING INNOVATION AND CAPITAL EFFICIENCY WITH STRONG LIQUIDITY POSITION
POSITIVE NEWS FLOW CHARACTERISES THIRD QUARTER 2013
HAMBURG, Germany, Nov. 12, 2013 (GLOBE NEWSWIRE) -- Evotec AG...
Evotec Announces TargetAD Collaboration With Johnson & Johnson Innovation to Identify and Develop Novel Alzheimer's Disease Therapies
08 nov. 2013 01h28 HE
|
Evotec AG
Collaborative effort will explore genes dysregulated in Alzheimer's disease patients to identify new targets for drug discovery and development
HAMBURG, Germany, Nov. 8, 2013 (GLOBE NEWSWIRE)...
Evotec to Report Results for the First Nine Months of 2013 on 12 November 2013
06 nov. 2013 04h00 HE
|
Evotec AG
HAMBURG, Germany, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for the first nine months of 2013 on Tuesday, 12 November...
Evotec and The Leukemia & Lymphoma Society Enter Into a Strategic Research Collaboration
05 nov. 2013 01h37 HE
|
Evotec AG
HAMBURG, Germany, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today that it has entered into an integrated research collaboration with The...
Evotec Achieves First Milestones in Multi-Target Deal With UCB
28 oct. 2013 02h44 HE
|
Evotec AG
HAMBURG, Germany, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) today announced that it has achieved first milestones in its multi-year, multi-target...
Evotec Enters Integrated Alliance With AstraZeneca in Kidney Disease
21 oct. 2013 01h47 HE
|
Evotec AG
HAMBURG, Germany, Oct. 21, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) today announced that it has signed an agreement with AstraZeneca in the field of kidney...
Evotec to Hold R&D Day 2013
16 oct. 2013 08h09 HE
|
Evotec AG
HAMBURG, Germany, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) announced today that its R&D Day 2013 will take place on 22 October 2013 in New York...
Evotec Receives Pre-Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim
15 oct. 2013 01h36 HE
|
Evotec AG
HAMBURG, Germany, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone...